News
RHHVF
436.25
-3.91%
-17.75
Roche Is Getting More Benefit Of The Doubt On Improving Execution
Seeking Alpha · 2d ago
Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News
Seeking Alpha · 4d ago
Weekly Report: what happened at RHHVF last week (0803-0807)?
Weekly Report · 5d ago
Amgen: The Market Is Underestimating Its Next Growth Phase
Seeking Alpha · 08/07 14:51
Positive Report for Roche Holding (RHHBY) from Morgan Stanley
TipRanks · 08/07 08:37
Roche upgraded to Overweight from Equal Weight at Morgan Stanley
TipRanks · 08/07 08:20
Teva Pharmaceuticals: Continuing To Execute On Its 'Pivot To Growth' Plan
Seeking Alpha · 08/05 20:05
Genprex announces collaboration with Roche Diagnostics
TipRanks · 08/03 11:11
Weekly Report: what happened at RHHVF last week (0727-0731)?
Weekly Report · 08/03 09:15
Oakmark Global All Cap Strategy Q2 2026 Portfolio Performance
Seeking Alpha · 07/29 04:40
Outlook: 'Hold' - Caution On LYTENAVA FDA Approval And Cash Needs
Seeking Alpha · 07/28 17:44
Analysts Conflicted on These Healthcare Names: Roche Holding AG (OtherRHHVF) and Atricure (ATRC)
TipRanks · 07/27 09:30
Weekly Report: what happened at RHHVF last week (0720-0724)?
Weekly Report · 07/27 09:15
Regeneron: I'm Not Concerned About The Declining ROIC And Operating Margins
Seeking Alpha · 07/25 00:22
Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Roche Holding AG (OtherRHHVF) and Quest Diagnostics (DGX)
TipRanks · 07/24 13:40
Roche announces EMA’s CHMP recommended approval of Susvimo
TipRanks · 07/24 12:50
Roche receives FDA 510(k) clearance for cobas BV/CV assay
TipRanks · 07/24 12:35
Bernstein Remains a Buy on Roche Holding AG (RHHVF)
TipRanks · 07/23 12:57
Roche confirms FY26 outlook
TipRanks · 07/23 10:16
Roche reports 1H group sales CHF 30.4B vs. CHF 30.9B last year
TipRanks · 07/23 10:10
More
Webull provides a variety of real-time RHHVF stock news. You can receive the latest news about Roche Hldg through multiple platforms. This information may help you make smarter investment decisions.
About RHHVF
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.